THERAPEUTICSMD, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+33.9% +$226K
$893K
Cost of Revenue
—
Gross Profit
—
R&D
—
SG&A↓-2.0% -$31K
$2M
D&A↓-3.0% -$3K
$97K
Operating Income↑+24.0% +$272K
$-862K
EBITDA↓-3.0% -$3K
$97K
Interest Expense
—
Interest Income↑+5.8% +$7K
$127K
Other Income/Expense↑+60.8% +$345K
$912K
Pretax Income↑+108.8% +$617K
$50K
Tax Provision↓-58.1% -$44K
$32K
Net Income↑+125.0% +$761K
$152K
Gross Margin
—
Operating Margin↑+97.4pts
-109.9%
Net Margin↑+130.7pts
19.4%
Effective Tax Rate
0.0%
Operating Lease Cost
—
Revenue YoY Variation↑+82.6pts
33.9%
Income YoY Variation↓-12.1pts
24.0%
Revenue QoQ Variation↓-8.0pts
13.9%
Income QoQ Variation↓-83.4pts
-24.0%